VREX
Varex Imaging Corp
NASDAQ · Healthcare · Medical - Devices · US
$18.49
−0.27%0
Insider buys (3m)
2
Insider sells (3m)
-$2.6M
Net value (3m)
+78.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 15, 2026 | Kunkel Jay K. · director | Sale | 8,121 | $18 |
| Sep 15, 2026 | Maheshwari Shubham · officer: Chief Financial Officer | M-Exempt | 160,944 | $14 |
| Sep 15, 2026 | Maheshwari Shubham · officer: Chief Financial Officer | Sale | 130,000 | $18 |
| Aug 18, 2026 | Aranki Karen L · officer: Chief Human Resources Officer | F-InKind | 1,145 | $18 |
| Aug 18, 2026 | Aranki Karen L · officer: Chief Human Resources Officer | M-Exempt | 3,974 | $0.00 |
| Mar 23, 2026 | Kunkel Jay K. · director | Sale | 4,510 | $11 |
| Feb 13, 2026 | GUERTIN TIMOTHY E · director | A-Award | 12,331 | $0.00 |
| Feb 13, 2026 | Chertoff Jocelyn D · director | A-Award | 12,331 | $0.00 |
| Feb 13, 2026 | TSINGOS CHRISTINE A · director | A-Award | 12,331 | $0.00 |
| Feb 13, 2026 | Kunkel Jay K. · director | A-Award | 12,331 | $0.00 |
| Feb 13, 2026 | Rosebrough Walter M Jr · director | A-Award | 14,947 | $0.00 |
| Feb 13, 2026 | Bardwell Kathleen · director | A-Award | 12,331 | $0.00 |
| Feb 10, 2026 | Kunkel Jay K. · director | M-Exempt | 8,483 | $0.00 |
| Feb 9, 2026 | GUERTIN TIMOTHY E · director | M-Exempt | 8,483 | $0.00 |
| Feb 9, 2026 | Bardwell Kathleen · director | M-Exempt | 8,483 | $0.00 |
| Feb 9, 2026 | Rosebrough Walter M Jr · director | M-Exempt | 10,339 | $0.00 |
| Feb 9, 2026 | Chertoff Jocelyn D · director | M-Exempt | 8,483 | $0.00 |
| Feb 9, 2026 | TSINGOS CHRISTINE A · director | M-Exempt | 8,483 | $0.00 |
| Dec 17, 2025 | Aranki Karen L · officer: Chief Human Resources Officer | A-Award | 2,155 | $0.00 |
| Dec 17, 2025 | Aranki Karen L · officer: Chief Human Resources Officer | A-Award | 2,633 | $0.00 |
| Dec 17, 2025 | Hartmann Andrew · officer: SVP and GM, Detectors | A-Award | 3,134 | $0.00 |
| Dec 17, 2025 | Jonaitis Mark S. · officer: SVP and GM, X-Ray Sources | A-Award | 2,565 | $0.00 |
| Dec 17, 2025 | Maheshwari Shubham · officer: Chief Financial Officer | A-Award | 5,520 | $0.00 |
| Dec 17, 2025 | Jonaitis Mark S. · officer: SVP and GM, X-Ray Sources | A-Award | 3,134 | $0.00 |
| Dec 17, 2025 | SANYAL SUNNY · director, officer: President and CEO | A-Award | 15,394 | $0.00 |
| Dec 17, 2025 | Maheshwari Shubham · officer: Chief Financial Officer | A-Award | 4,515 | $0.00 |
| Dec 17, 2025 | SANYAL SUNNY · director, officer: President and CEO | A-Award | 18,801 | $0.00 |
| Dec 17, 2025 | Hartmann Andrew · officer: SVP and GM, Detectors | A-Award | 2,565 | $0.00 |
| Dec 12, 2025 | Jonaitis Mark S. · officer: SVP and GM, X-Ray Sources | M-Exempt | 4,664 | $0.00 |
| Dec 12, 2025 | Jonaitis Mark S. · officer: SVP and GM, X-Ray Sources | A-Award | 26,041 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 57Increased 131Reduced 115Sold out 20
| Filer | Action | Shares | Filed |
|---|---|---|---|
| PZENA INVESTMENT MANAGEMENT LLC | Increased | 4,344,381 | Aug 7, 2026 |
| PZENA INVESTMENT MANAGEMENT LLC | Increased | 3,992,280 | Apr 24, 2026 |
| BlackRock, Inc. | Increased | 3,894,891 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 3,817,830 | May 13, 2026 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | Reduced | 2,647,263 | May 5, 2026 |
| Allspring Global Investments Holdings, LLC | Reduced | 2,283,986 | Aug 13, 2026 |
| Neuberger Berman Group LLC | Increased | 2,082,597 | Aug 13, 2026 |
| NEUBERGER BERMAN GROUP LLC | Increased | 1,924,949 | May 14, 2026 |
| LSV ASSET MANAGEMENT | Increased | 1,869,944 | Aug 6, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 1,867,162 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,820,336 | May 15, 2026 |
| LSV ASSET MANAGEMENT | Increased | 1,762,096 | May 11, 2026 |
| DIMENSIONAL FUND ADVISORS LP | Reduced | 1,557,777 | May 7, 2026 |
| RICE HALL JAMES & ASSOCIATES, LLC | Increased | 1,445,853 | Aug 7, 2026 |
| COOKE & BIELER LP | Reduced | 1,303,012 | May 4, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 15, 2026